Gilead awards $7.6M in grants to 24 organizations for breast cancer
Justin Sullivan/Getty Images News                 

Gilead Sciences (NASDAQ:GILD) said it had awarded $7.6M in grant funding to 24 U.S.-basedÂ organizations throughÂ Advance Health Equity in breast cancer.
The funding will support patient navigator training, cultural competency training, and services combating barriers such as transportation.
The oncology grant builds on Gileadâs 2022 program, which provided $5.7M in grants to 21 U.S. organizations for programs working to advance health equity for Black people impacted by triple-negative breast cancer.